BIG NEWS To all our valued customers, Direct Sarms is rebranding as such we are offering an exclusive discount of 45% OFF all SARMs for a limited time.
Please be aware of our revised hours during the holiday season. We will operate on a half-day schedule on December 24th and 31st and will be CLOSED from December 25th to 28th, with limited customer service available. We will fully REOPEN on December 29th and again on January 2nd.
Triptorelin Ireland research peptide belongs to the class of GnRH (Gonadotropin-Releasing Hormone) agonists, acting as a potent regulator of hormone secretion. By modulating the release of gonadotropins, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH), Triptorelin influences the delicate balance of reproductive hormones. This modulation enables Ireland scientists to investigate the underlying mechanisms of reproductive health, fertility, and associated disorders.
Moreover, Ireland Triptorelin research peptide has garnered attention for its potential therapeutic applications. It has been extensively studied in the management of hormone-related conditions such as prostate cancer, endometriosis, and precocious puberty. By suppressing hormone release, Triptorelin helps mitigate disease progression and improve patient outcomes.


